H
61.13
-0.13 (-0.21%)
| 前收盘价格 | 61.26 |
| 收盘价格 | 60.82 |
| 成交量 | 59 |
| 平均成交量 (3个月) | 3,136 |
| 市值 | 16,362,277,888 |
| 市盈率 (P/E TTM) | 10.10 |
| 52周波幅 | |
| 利润日期 | 30 Apr 2025 - 5 May 2025 |
| 营业毛利率 | 13.83% |
| 营业利益率 (TTM) | 22.17% |
| 稀释每股收益 (EPS TTM) | 6.05 |
| 季度收入增长率 (YOY) | -1.20% |
| 季度盈利增长率 (YOY) | -18.50% |
| 总债务/股东权益 (D/E MRQ) | 54.80% |
| 流动比率 (MRQ) | 3.24 |
| 营业现金流 (OCF TTM) | 1.13 B |
| 杠杆自由现金流 (LFCF TTM) | 775.88 M |
| 资产报酬率 (ROA TTM) | 6.92% |
| 股东权益报酬率 (ROE TTM) | 11.77% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Medical Instruments & Supplies (GB) | 混合的 | 混合的 |
| Medical Instruments & Supplies (全球的) | 看跌 | 看跌 | |
| 股票 | HOLOGIC INC HOLOGIC ORD SHS | - | - |
AIStockmoo 评分
0.4
| 分析师共识 | 0.0 |
| 内部交易活动 | NA |
| 价格波动 | 3.5 |
| 技术平均移动指标 | -2.5 |
| 技术振荡指标 | 0.5 |
| 平均 | 0.38 |
相关股票
| 股票 | 市值 | DY | P/E（TTM） | P/B |
|---|---|---|---|---|
| HOLOGIC INC HOLOGIC ORD SHS | 16 B | - | 10.10 | - |
| BECTON DICKINSON AND CO BECTON | 47 B | 2.27% | 27.35 | - |
| RESMED INC RESMED ORD SHS | 35 B | 0.80% | 47.35 | - |
| CONVATEC GROUP PLC ORD 10P | 5 B | 0.02% | 37.49 | 4.38 |
| COOPER COMPANIES INC COOPER ORD | 4 B | - | 4.31 | - |
| TECAN GROUP AG TECAN GROUP ORD | 2 B | 1.87% | 16.55 | - |
|
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in five segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts. |
|
| 部门 | Healthcare |
| 行业 | Medical Instruments & Supplies |
| 投资方式 | Mid Core |
| 内部持股比例 | 0.86% |
| 机构持股比例 | 102.61% |
该时间范围内无数据。
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合